LYFE Capital Closes $298 Million China Healthcare Fund

LYFE Capital closed its first fund, which will invest in China healthcare growth stage companies, with $298 million. The funds are comprised of US$210 million and CN¥555.  The company said the LYFE Capital Fund I would make equity investments in China healthcare companies starting from early growth stage. The company will seek to identify companies with marketed products that want to expand internationally. More details.... Share this with colleagues: // //